A slew of start-ups and academic labs are leaning on AI agents and bots, rather than humans, to speed up their chemistry ...

The Bundibugyo strain of Ebola causing the ongoing outbreak in the Democratic Republic of Congo currently has no vaccine. The Conversation Weekly podcast speaks to two researchers working to develop ...

Is CMPS a good stock to buy? We came across a bullish thesis on COMPASS Pathways plc on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on CMPS.

AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.

LinkedIn has been a recurring source of breaches at AstraZeneca in recent years. The LinkedIn activities of AstraZeneca employees have yet again landed the drugmaker in hot water, with the U.K.

Unilever's Rianne Buter explains why the firm has joined the 24/7 Coalition to ensure it can totally eliminate emissions from ...

Zak Wojnar of Newsweek chats with Leah McKendrick about her delightful new Netflix romantic comedy, "Voicemails for Isabelle" ...

US News Editor at Express US. She previously worked as Deputy Video News Editor at the Daily Express. If you think you have a ...

AstraZeneca’s experimental GLP-1 pill cut body weight by nearly 12% in obese patients over 36 weeks and reduced A1C, a metric for blood-sugar levels, by 1.9 percentage points on average in diabetic ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

In this video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights recent coverage of the myriad ways federal policies are impacting health care, from Medicare ...

The phase 3 findings position AZ's Imfinzi/Imjudo duo to take on an earlier setting of its approved liver cancer usage. (Darren Incorvaia) AstraZeneca is polishing the case for its Imfinzi (durvalumab ...